Announcements Trials
Browse Landscape

Phase

Phase NA 3Phase 1 1

Status

Terminated 3Completed 1

Sponsor Class

OTHER 3NETWORK 1

Study Type

Interventional 4

Sponsor

Cancer Type

Breast 8Gynecologic 4Gastrointestinal 3Head & Neck 2Dermatologic 2Tumor-Agnostic 1Sarcoma 1

Conditions

Endometrial Neoplasms 3Uterine Cervical Neoplasms 1

Interventions

Paclitaxel 575Carboplatin 521Cisplatin 351Bevacizumab 252pembrolizumab 228Gemcitabine 157Topotecan 128Cyclophosphamide 128liposomal doxorubicin 127olaparib 120Taxes 113Radiotherapy 110Docetaxel 94Brachytherapy 89Doxorubicin 84Drug Therapy 81niraparib 75Nivolumab 71Magnetic Resonance Spectroscopy 71Specimen Handling 65fludarabine 57Biopsy 55Hyperthermic Intraperitoneal Chemotherapy 53Filgrastim 52Letrozole 50Oxaliplatin 48durvalumab 47Immunoglobulin G 47atezolizumab 46Platinum 44

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Interventional × iso-sulfan blue × Gynecologic × Clear all
NCT01818739 2023-03-22

Lymph Node Mapping in Patients With Endometrial Cancer

Ohio State University Comprehensive Cancer Center

Phase NA Completed
204 enrolled 4 charts
Gynecologic

Endometrial Neoplasms

NCT01939028 2020-08-27

Lymph Node Mapping in Patients With Newly Diagnosed Endometrial Cancer Undergoing Surgery

Case Comprehensive Cancer Center

Phase NA Terminated
58 enrolled 12 charts
Gynecologic

Endometrial Neoplasms

NCT02589366 2018-10-15

Lymphoseek as Lymphoid Tissue Targeting Agent in Patients With Cancer of the Endometrium

University of California, San Diego

Phase 1 Terminated
2 enrolled
Gynecologic

Endometrial Neoplasms

NCT00070317 2017-11-06

Lymph Node Mapping and Sentinel Lymph Node Identification in Patients With Stage IB1 Cervical Cancer

GOG Foundation

Phase NA Terminated
102 enrolled 6 charts
Gynecologic

Uterine Cervical Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡